Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma

Authors: Esterberg, Elizabeth, Iyer, Shrividya, Nagar, Saurabh P., Davis, Keith L., Tannir, Nizar M.

Source: In Clinical Genitourinary Cancer April 2024 22(2):115-125

Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib

Authors: Paik, Paul K, Goyal, Ravi K, Cai, Beilei, Price, Mark A, Davis, Keith L, Ansquer, Valerie Derrien, Caro, Nydia, Saliba, Teddy R

Source: Future oncology. 19(3):217-228

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100189948700.0x000001&indx=1&recIds=ETOCvdc_100189948700.0x000001

Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review

Authors: Wolf, Jürgen, Souquet, Pierre-Jean, Goto, Koichi, Cortot, Alexis, Baik, Christina, Heist, Rebecca, Kim, Tae Min, Han, Ji-Youn, Neal, Joel W., Mansfield, Aaron S., Gilloteau, Isabelle, Nwana, Ngozi, Waldron-Lynch, Maeve, Davis, Keith L., Giovannini, Monica, Awad, Mark M.

Source: In Clinical Lung Cancer November 2023 24(7):641-650

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Authors: Salles, Gilles, Schuster, Stephen J., Dreyling, Martin, Fischer, Luca, Kuruvilla, John, Patten, Piers E. M., von Tresckow, Bastian, Smith, Sonali M., Jiménez-Ubieto, Ana, Davis, Keith L., Anjos, Carla, Chu, Jufen, Zhang, Jie, Lobetti Bodoni, Chiara, Thieblemont, Catherine, Fowler, Nathan H., Dickinson, Michael, Martínez-López, Joaquin, Wang, Yucai, Link, Brian K.

Source: In Blood Advances 22 November 2022 6(22):5835-5843

Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review

Authors: Passamonti, Francesco, Heidel, Florian H, Parikh, Rohan C, Ajmera, Mayank, Tang, Derek, Nadal, Jose Alberto, Davis, Keith L, Abraham, Pranav

Source: Future oncology. 18(18):2217-2231

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191335250.0x000001&indx=1&recIds=ETOCvdc_100191335250.0x000001

Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib.

Authors: Passamonti, Francesco, Korgaonkar, Siddhi, Parikh, Rohan C, Chevli, Manoj, Yucel, Aylin, Rombi, Julien, Jones, Shalon, Zissler, Dorothy, Davis, Keith L, Slaff, Samantha

Source: Future Oncology; Feb2025, Vol. 21 Issue 5, p579-591, 13p

Real‐world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK

Authors: Hillmen, Peter, Xie, Jing, Yong, Alan S. M., Waweru, Catherine, Sorof, Thuy Anh, Goyal, Ravi K., Davis, Keith L.

Source: EJHaem. 2(2):219-227

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122888340.0x000001&indx=1&recIds=ETOCvdc_100122888340.0x000001

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

Authors: Goyal, Ravi K., Nagar, Saurabh P., Kabadi, Shaum M., Le, Hannah, Davis, Keith L., Kaye, James A.

Source: Cancer medicine. 10(8):2690-2702

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100119162781.0x000001&indx=1&recIds=ETOCvdc_100119162781.0x000001

Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA

Authors: Singal, Amit G, Nagar, Saurabh P, Hitchens, Abby, Davis, Keith L, Iyer, Shrividya

Source: Future oncology. 17(21):2759-2768

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187781073.0x000001&indx=1&recIds=ETOCvdc_100187781073.0x000001

Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States

Authors: Goyal, Ravi K., Cuyun Carter, Gebra, Nagar, Saurabh P., Nash Smyth, Emily, Price, Gregory L., Parikh, Rohan C., Huang, Yu-Jing, Li, Li, Davis, Keith L., Kaye, James A.

Source: Expert review of pharmacoeconomics & outcomes research. 21(4):699-710

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128564704.0x000001&indx=1&recIds=ETOCvdc_100128564704.0x000001

Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis

Authors: Singal, Amit G., Nagar, Saurabh P., Hitchens, Abby, Davis, Keith L., Iyer, Shrividya

Source: Clinical gastroenterology and hepatology. 21(3):830-831.e1

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183939412.0x000001&indx=1&recIds=ETOCvdc_100183939412.0x000001

Real‐world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice

Authors: Singal, Amit G., Nagar, Saurabh P., Hitchens, Abby, Davis, Keith L., Iyer, Shrividya

Source: Cancer reports. 6(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177305877.0x000001&indx=1&recIds=ETOCvdc_100177305877.0x000001

Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2− Advanced Breast Cancer Enrolled in an Expanded Access Program

Authors: Brufsky, Adam, Mitra, Debanjali, Davis, Keith L., Nagar, Saurabh P., McRoy, Lynn, Cotter, Matthew J., Stearns, Vered

Source: In Clinical Breast Cancer October 2019 19(5):317-325

POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancer

Authors: Tripathy, Debasish, Blum, Joanne L, Rocque, Gabrielle B, Bardia, Aditya, Karuturi, Meghan S, Cappelleri, Joseph C, Liu, Yuan, Zhang, Zhe, Davis, Keith L, Wang, Yao

Source: Future oncology. 16(31):2475-2485

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186991034.0x000001&indx=1&recIds=ETOCvdc_100186991034.0x000001

Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.

Authors: Mody, Freny Vaghaiwalla, Goyal, Ravi K., Ajmera, Mayank, Davis, Keith L., Amin, Alpesh N.

Source: Drugs - Real World Outcomes; Sep2024, Vol. 11 Issue 3, p501-511, 11p

Subject Terms: HEART failure patients, ANGIOTENSIN converting enzyme, PATIENT readmissions, HEART beat, VENTRICULAR ejection fraction, MULTIVARIABLE testing

Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study.

Authors: Furqan, Muhammad, Karanth, Siddharth, Goyal, Ravi K, Cai, Beilei, Rombi, Julien, Davis, Keith L, Caro, Nydia, Saliba, Teddy

Source: Future Oncology; 2024, Vol. 20 Issue 22, p1553-1563, 11p

Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer

Authors: Horn, Leora, Bauml, Joshua, Forde, Patrick M., Davis, Keith L., Myall, Nathaniel J., Sasane, Medha, Dalal, Anand, Culver, Ken, Wozniak, Antoinette J., Baik, Christina S., Mutebi, Alex, Zhang, Pingkuan, Wakelee, Heather A., Johnson, Bruce E.

Source: In Lung Cancer February 2019 128:74-90

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer

Authors: Goyal, Ravi K., Carter, Gebra Cuyun, Nagar, Saurabh P., Smyth, Emily N., Price, Gregory L., Huang, Yu-Jing, Li, Li, Davis, Keith L., Kaye, James A.

Source: Current medical research and opinion. 35(10):1699-1710

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110685131.0x000001&indx=1&recIds=ETOCvdc_100110685131.0x000001

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States

Authors: Kabadi, Shaum M., Goyal, Ravi K., Nagar, Saurabh P., Kaye, James A., Davis, Keith L.

Source: Cancer medicine. 8(8):3803-3810

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100086729475.0x000001&indx=1&recIds=ETOCvdc_100086729475.0x000001

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice

Authors: Blonde, Lawrence, Brunton, Stephen A., Chava, Pavan, Zhou, Rong, Meyers, Juliana, Davis, Keith L., Dalal, Mehul R., DiGenio, Andres

Source: Diabetes spectrum. 32(2):93-103

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620067543&indx=1&recIds=ETOCRN620067543